Welcome To NewsFlash Extra

Current NewsFlash Bulletins And Extras Latest stories in OTC.newsflash   14 November 2008,  NIELSEN CHALLENGES PERCEPTION OF Rx-to-OTC SWITCH   14 November 2008,  NOVARTIS SET TO BOOST OTC PRESENCE IN CHINA   14 November 2008,  INTERNATIONAL SALES DRIVE GROWTH FOR DIRECT MARKETER HERBALIFE   14 November 2008,  NBTY SPREADS BETS WITH DUAL RETAIL AND DIRECT SALES FOCUS   14 November 2008,  TOTAL PLANS TO SELL OFF SANOFI-AVENTIS STAKE   14 November 2008,  MORE SWITCH PLs ON HORIZON FOR PERRIGO   14 November 2008,  EGIS SEEKS ACQUISITION IN CEE   14 November 2008,  NESTLE OPENS R&D CENTRE IN BEIJING   14 November 2008,  CHINA SKY ONE OBTAINS PRODUCTION RIGHTS FOR NEW MEDICINES   14 November 2008,  ROHTO Q2 SALES DRIVEN BY SKIN CARE   14 November 2008,  MERCKLE TO SELL RATIOPHARM?   14 November 2008,  SCHWABE’S ENZYMATIC THERAPY ACQUISITION COMPLETE   14 November 2008,  ELDER PHARMA TO MARKET DAIWA PRODUCTS IN INDIA   14 November 2008,  ASKA, ACTAVIS FORM JAPANESE J-V   14 November 2008,  GSK “REINVENTS” PARACETAMOL   14 November 2008,  1ST OTC ORAL ANTIBIOTIC LAUNCHED IN UK   14 November 2008,  DRAMATIC CV RISK REDUCTION IN STATIN TRIAL   14 November 2008,  POSITIVE EFSA OPINION FOR BENECOL HEALTH CLAIM   14 November 2008,  VITAMIN C PRICES TO BE RAISED TO BOOST PRODUCTION?   14 November 2008,  OLDER TREATMENTS BEST FOR IBS?   14 November 2008,  PHR UNVEILS AMBITIOUS “PHARMACY CHAIN” PLAN   14 November 2008,  THIRD OF FRENCH PHARMACIES OFFER SELF-SELECTION   14 November 2008,  ONOFRE FORMS UNUSUAL PARTNERSHIP   14 November 2008,  AND FINALLY BE CAREFUL WHAT YOU SEARCH FOR ON GOOGLE Current NewsFlash Extras Company Profiles   31 October 2008,  Bayer profile REVISED, FDA WARNING LETTERS FOR ASPIRIN COMBOS   19 September 2008,  BMS Profile   14 November 2008,  Boehringer Ingelheim profile REVISED, NEW RESEARCH ON IBS TREATMENTS SUGGESTS HYOSCINE IS 1ST LINE APPROACH   17 October 2008,  Cadbury Profile   07 November 2008,  Daiichi-Sankyo REVISED, Q2 SALES HIT BY SLOW GROWTH FOR TRANSINO   07 November 2008,  GSK profile REVISED, "REINVENTS" PARACETAMOL WITH PANADOL ADVANCE   19 May 2008,  Hayao   14 November 2008,  J&J profile REVISED, NIELSEN / WOLTERS KLUWER STUDY CHALLENGES SWITCH PERCEPTION BASED ON ZYRTEC OTC RESEARCH   31 October 2008,  Merck profile REVISED, Q3 HIT BY CURRENCY EFFECTS   14 November 2008,  NBTY profile REVISED, REVEALS GROWTH ABOVE STRONG INDUSTRY RATE; TO BUILD DIRECT SALES   14 November 2008,  Novartis profile REVISED, SET TO BOOST OTC PRESENCE IN CHINA   07 July 2008,  Nycomed   04 April 2008,  Otsuka profile   31 October 2008,  P&G profile REVISED, PRILOSEC OTC HURT BY PRIVATE LABELS   31 October 2008,  Reckitt Benckiser profile REVISED, BEATS Q3 2008 FORECAST   14 November 2008,  Rohto profile REVISED, H1 08 SALES UP 4.5%   14 November 2008,  Sanofi-Aventis profile REVISED, TOTAL TO DIVEST ENTIRE HOLDING   07 November 2008,  Schering-Plough profile REVISED, FDA PROPOSES TO REVOKE ANDAs FOR Rx GENERIC VERSIONS OF MIRALAX   07 November 2008,  Taisho Profile REVISED, OTC MARKET 'UNFAVOURABLE' IN FISCAL Q2   07 November 2008,  Takeda Profile REVISED, CUTS FY EARNINGS FORECAST   14 March 2008,  World's Top 20 OTC Players 2007   24 October 2008,  Wyeth profile M&A Registers   25 January 2008,  M&A Register 1996-2007   14 November 2008,  M&A Register 2008 Hot Topics   04 May 2007,  Advisory OTCs   29 October 2004,  Deregulation in Japan   27 October 2006,  German healthcare reforms   17 February 2006,  Guest Feature - Wellness in the OTC World (Suresh Kumar)   04 February 2005,  RFID News Briefings   14 May 2007,  Aché: The Aché Story   17 December 2004,  Acne remedies global leading brands   06 May 2005,  Australia OTC market 2000-04   07 December 2007,  BMS OTC Brands   02 February 2007,  BMS, Sanofi-Aventis M&A Review & Analysis   01 September 2006,  Brazil OTC market briefing   15 June 2007,  Brazil: Progress of Top Systemic Analgesic Brands   13 April 2007,  CEE Local Players   19 October 2007,  China's Top OTC Marketers   21 September 2007,  Consumer Healthcare Profit Margins   03 September 2004,  Ephedra briefing   12 March 2004,  European generics and private label   27 May 2005,  Growth in Europe's major OTC markets   22 December 2006,  J&J's acquisition of Pfizer CH - Briefing & analysis   31 March 2006,  Japan briefing   23 September 2005,  Mexico OTC briefing   14 October 2005,  Mid-year trends 2005   01 June 2007,  NRT per capita spend 2006 in the Top 20 OTC Markets   23 February 2007,  Nycomed acquires Altana Pharma – the Facts and Figures   08 October 2004,  Per capita spends on OTC   31 August 2007,  PSE briefing   09 March 2007,  PSE: UK MHRA Consultation on reverse-switch   29 August 2008,  Russia's Top OTC Marketers   10 October 2008,  Rx-to-OTC Switch: The Key Factors to Consider   08 April 2005,  Taiwan OTC market briefing   23 April 2007,  The Nicholas Hall Awards 2007   11 November 2005,  UK price wars   24 March 2005,  US OTC allergy remedies: Claritin's impact   09 May 2008,  Wal-Mart's US$4 OTC Range – Brand & Private Label Price Comparisons Nicholas Halls Overviews   05 October 2007,  DB6 2007: Mid Year Briefing   06 February 2004,  Global trends H2 2003   05 October 2004,  Nicholas Hall at the Sino-US Drugstore Forum   16 April 2004,  Nicholas Hall previews DB6 2004   16 April 2004,  Nicholas Hall reviews CHPA meeting   13 April 2006,  OTC Growth Companies   04 March 2005,  OTC market trends & data 2004:   18 May 2007,  OTC Network Partners @ Nicholas Hall   17 February 2006,  Provisional Global OTC Figures for 2005